Switch headers Switch to TIGweb.org

Are you an TIG Member?
Click here to switch to TIGweb.org

HomeHomeExpress YourselfPanoramaMMPR Denying Patients Freedom To Grow Medicine
a TakingITGlobal online publication

(Advanced Search)

Panorama Home
Issue Archive
Current Issue
Next Issue
Featured Writer
TIG Magazine
Short Story
My Content

This work is licensed under a Creative Commons License.
MMPR Denying Patients Freedom To Grow Medicine Printable Version PRINTABLE VERSION
by Des, Canada Mar 10, 2013
Culture , Health , Human Rights   Opinions


MMPR Denying Patients Freedom To Grow Medicine MMPR info:

Proposed Marihuana for Medical Purposes Regulations

Government Objectives-
Treat marijuana as much as possible like a medication
Authorize 3 key activities
1. The possession of Marijuana for medical purposes
by individuals who have the support of an authorized health care provider
2. The production of Marijuana by licensed producers
3. The sale and distribution of dried Marijuana by specific regulated parties to individuals who can possess it.

The government anticipates this will make accessing marijuana for medical purposes more efficient for program participants, and give patients more options for obtaining support from authorized health care practicioners, more choices of strains, and suppliers, and provide increased access to quality controlled marijuana.

At the same time the new regulations will prevent patients from growing their own medicine.
This is said to address public health and safety concerns raised by stake holders. Opening the market to legal commercial growers should not come at the expense of patients. Crimes including homicide have been decreasing for the last 20 years, yet the Canadian justice system is incarcerating more Canadians than ever, why is that?

The proposed MMPR assumes an estimated price increase from $1.80/g to $5.00/g and then $7.60/g by 2014. The qualitative analysis and quantitative evaluations done by the government expects benefits of MMPR may take more than 10 years to emerge.

This is the governments reaction to possible abuses of MMAR
The MMAR enables Canadians with serious medical conditions access to medical marijuana. The therapeutic effects of cannibinoids are being continuously researched in Canada and internationally.

The Cannabis available to MMAR patients is cultivated under exclusive license by Prairie Plant Systems (Saskatoon, SK)

124,000 members of the American College of Physicians have endorsed the use of marrijuana for it's medical value

You can access the proposed regulations through Health Canada’s website at:

Doctors that sign MMAR exemptions-

How to speak to your doctor about medical marijuana
*Bring for b1 or b2
*get passport photos
*make a list of therapies or medications you have tried
*identify symptoms that can be managed with marijuana
*tell doctor how you are injesting marijuana
*give doctor info sheet from www.canadamedicalmarijuana.com
*consider bringing CMPA release form for medical practioners

The CCIC is a federally registered Canadian nonprofit organization of basic and clinical researchers and health care professionals established to promote evidence-based research and education concerning the endocannabinoid system and therapeutic applications of endocannabinoid and cannabinoid agents.

Patients who oppose new regulations



You must be logged in to add tags.

Writer Profile

This user has not written anything in his panorama profile yet.
You must be a TakingITGlobal member to post a comment. Sign up for free or login.